FDA Approves Firdapse (amifampridine) for Lambert-Eaton Myasthenic Syndrome

November 28, 2018 -- The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a rare autoimmune disorder that affects the connection...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news